85 related articles for article (PubMed ID: 9040988)
21. Synthesis and biological evaluation of 3-(azolylmethyl)-1H-indoles and 3-(alpha-azolylbenzyl)-1H-indoles as selective aromatase inhibitors.
Le Borgne M; Marchand P; Nourrisson MR; Loquet D; Palzer M; Le Baut G; Hartmann RW
J Enzyme Inhib Med Chem; 2007 Oct; 22(5):667-76. PubMed ID: 18035835
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation of pregnane derivatives as inhibitors of human testicular 17 alpha-hydroxylase/C17,20-lyase.
Li JS; Li Y; Son C; Brodie AM
J Med Chem; 1996 Oct; 39(21):4335-9. PubMed ID: 8863811
[TBL] [Abstract][Full Text] [Related]
23. Novel 17-azolyl steroids, potent inhibitors of human cytochrome 17 alpha-hydroxylase-C17,20-lyase (P450(17) alpha): potential agents for the treatment of prostate cancer.
Njar VC; Kato K; Nnane IP; Grigoryev DN; Long BJ; Brodie AM
J Med Chem; 1998 Mar; 41(6):902-12. PubMed ID: 9526564
[TBL] [Abstract][Full Text] [Related]
24. Pyridyl substituted benzocycloalkenes: new inhibitors of 17 alpha-hydroxylase/17,20-lyase (P450 17 alpha).
Sergejew T; Hartmann RW
J Enzyme Inhib; 1994; 8(2):113-22. PubMed ID: 7539071
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
Kellis JT; Vickery LE
Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577
[TBL] [Abstract][Full Text] [Related]
26. 1-[(Benzofuran-2-yl)phenylmethyl]triazoles as steroidogenic inhibitors: synthesis and in vitro inhibition of human placental CYP19 aromatase.
Vinh TK; Yee SW; Kirby AJ; Nicholls PJ; Simons C
Anticancer Drug Des; 2001; 16(4-5):217-25. PubMed ID: 12049480
[TBL] [Abstract][Full Text] [Related]
27. Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 arom.
Hartmann RW; Bayer H; Grün G; Sergejew T; Bartz U; Mitrenga M
J Med Chem; 1995 Jun; 38(12):2103-11. PubMed ID: 7783141
[TBL] [Abstract][Full Text] [Related]
28. The use of the substrate-heme complex approach in the design, synthesis, biochemical evaluation, and rationalization of the inhibitory activity of a range of azole compounds against cholesterol side chain cleavage enzyme.
Ahmed S
Biochem Biophys Res Commun; 2000 Aug; 275(1):75-6. PubMed ID: 10944444
[TBL] [Abstract][Full Text] [Related]
29. 17-Imidazolyl, pyrazolyl, and isoxazolyl androstene derivatives. Novel steroidal inhibitors of human cytochrome C17,20-lyase (P450(17 alpha).
Ling YZ; Li JS; Liu Y; Kato K; Klus GT; Brodie A
J Med Chem; 1997 Sep; 40(20):3297-304. PubMed ID: 9379450
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and aromatase-inhibitory activity of imidazolyl-1,3,5-triazine derivatives.
Matsuno T; Kato M; Tsuchida Y; Takahashi M; Yaguchi S; Terada S
Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):291-6. PubMed ID: 9118443
[TBL] [Abstract][Full Text] [Related]
31. Active site-directed inhibitors of steroid hydroxylase cytochromes P450.
Vickery LE
Methods Enzymol; 1991; 206():548-58. PubMed ID: 1784241
[No Abstract] [Full Text] [Related]
32. 3- and 4-pyridylalkyl adamantanecarboxylates: inhibitors of human cytochrome P450(17 alpha) (17 alpha-hydroxylase/C17,20-lyase). Potential nonsteroidal agents for the treatment of prostatic cancer.
Chan FC; Potter GA; Barrie SE; Haynes BP; Rowlands MG; Houghton J; Jarman M
J Med Chem; 1996 Aug; 39(17):3319-23. PubMed ID: 8765515
[TBL] [Abstract][Full Text] [Related]
33. Some 1-[(benzofuran-2-yl)methyl]imidazoles as inhibitors of 17 alpha-hydroxylase: 17, 20-lyase (P450 17) and their specificity patterns.
Bahshwan SA; Owen CP; Nicholls PJ; Smith HJ; Ahmadi M
J Pharm Pharmacol; 1998 Oct; 50(10):1109-16. PubMed ID: 9821656
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and aromatase inhibitory activity of novel 1-(4-aminophenyl)-3-azabicyclo[3.1.0]hexane- and -[3.1.1]heptane-2,4- diones.
Stanek J; Alder A; Bellus D; Bhatnagar AS; Häusler A; Schieweck K
J Med Chem; 1991 Apr; 34(4):1329-34. PubMed ID: 2016706
[TBL] [Abstract][Full Text] [Related]
35. A novel activity for a group of sesquiterpene lactones: inhibition of aromatase.
Blanco JG; Gil RR; Alvarez CI; Patrito LC; Genti-Raimondi S; Flury A
FEBS Lett; 1997 Jun; 409(3):396-400. PubMed ID: 9224697
[TBL] [Abstract][Full Text] [Related]
36. Imidazole substituted biphenyls: a new class of highly potent and in vivo active inhibitors of P450 17 as potential therapeutics for treatment of prostate cancer.
Wachall BG; Hector M; Zhuang Y; Hartmann RW
Bioorg Med Chem; 1999 Sep; 7(9):1913-24. PubMed ID: 10530940
[TBL] [Abstract][Full Text] [Related]
37. Aromatase inhibition by an 11,13-dihydroderivative of a sesquiterpene lactone.
Blanco JG; Gil RR; Bocco JL; Meragelman TL; Genti-Raimondi S; Flury A
J Pharmacol Exp Ther; 2001 Jun; 297(3):1099-105. PubMed ID: 11356934
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of testicular microsomal cytochrome P-450 (17 alpha-hydroxylase/C-17,20-lyase) by estrogens.
Onoda M; Hall PF
Endocrinology; 1981 Sep; 109(3):763-7. PubMed ID: 6973463
[TBL] [Abstract][Full Text] [Related]
39. Cholesterol side-chain cleavage activity in human placenta and bovine adrenals: an one-step method for separation of pregnenolone formed in vitro.
Pasanen M; Pelkonen O
Steroids; 1984 May; 43(5):517-27. PubMed ID: 6549417
[TBL] [Abstract][Full Text] [Related]
40. Some 3-(4-aminophenyl)pyrrolidine-2,5-diones as all-trans-retinoic acid metabolising enzyme inhibitors (RAMBAs).
Kirby AJ; Lelain R; Mason P; Maharlouie F; Nicholls PJ; Smith HJ; Simons C
J Enzyme Inhib Med Chem; 2002 Oct; 17(5):321-7. PubMed ID: 12683748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
